Difference between revisions of "QMS"
(How do you know each other? <a href=" http://ignconvention.com/bahrain/?p=suppliers-of-cialis-in-uk ">sous-ordres suspecte cours du cialis 20 mg</a> In 2010 the country had threatened to impose a ban) |
(I'm on holiday <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">depakote er half life</a> The accuracy of 23andMeâs DNA tests is central to FDAâs concerns. A false positive resu) |
||
| Line 1: | Line 1: | ||
| − | + | I'm on holiday <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">depakote er half life</a> The accuracy of 23andMeâs DNA tests is central to FDAâs concerns. A false positive result could lead consumers to seek unnecessary and possibly harmful screening or treatment, regulators worry, while a false negative could allow a major risk to go unnoticed. FDA found tests predicting a personâs sensitivity to certain drugs, including the anticoagulant warfarin, to be âparticularly concerning,â saying that people may change their dosage or discontinue a drug without professional advice. The letter scolds 23andMe for failing to provide evidence to the FDA that its tests work: âMore than 5 years after you began marketing, you still had not completed some of the studies and had not even started other studies necessary to support a marketing submission for the PGS.â | |
| − | + | ||
Revision as of 14:22, 13 February 2015
I'm on holiday <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">depakote er half life</a> The accuracy of 23andMeâs DNA tests is central to FDAâs concerns. A false positive result could lead consumers to seek unnecessary and possibly harmful screening or treatment, regulators worry, while a false negative could allow a major risk to go unnoticed. FDA found tests predicting a personâs sensitivity to certain drugs, including the anticoagulant warfarin, to be âparticularly concerning,â saying that people may change their dosage or discontinue a drug without professional advice. The letter scolds 23andMe for failing to provide evidence to the FDA that its tests work: âMore than 5 years after you began marketing, you still had not completed some of the studies and had not even started other studies necessary to support a marketing submission for the PGS.â
